📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

KABRADGPharmaceuticals

Kabra Drugs Ltd — Financial Ratios & Key Metrics

₹24.58

-3.19%

P/E Ratio62.38xIndustry: 31.77x

ROE-8.47%Return on equity

ROCE-7.82%Return on capital

Debt/Equity0.02Low debt

💎

Valuation & Profitability

P/E Ratio

62.38x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹74.23 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+65.49%

3 Months

+70.72%

6 Months

+169.22%

1 Year

+226.49%

52W Low

₹11

Current

₹25

52W High

₹36

56% of 52-week range — Mid range

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹30

▼ Price below SMA 50 — Bearish

SMA 200

₹23

▲ Long-term uptrend

Volume Signal

102% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Kabra Drugs Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.